Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1285) 1285
Patent (847) 847
Conference Proceeding (58) 58
Book Review (34) 34
Publication (18) 18
Book / eBook (8) 8
Book Chapter (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (702) 702
humans (634) 634
male (438) 438
female (405) 405
middle aged (365) 365
aged (343) 343
physics (335) 335
oncology (327) 327
chemistry (321) 321
metallurgy (319) 319
adult (237) 237
cancer (214) 214
human necessities (213) 213
prognosis (186) 186
performing operations (179) 179
transporting (179) 179
electricity (177) 177
aged, 80 and over (167) 167
optics (165) 165
surgery (162) 162
hygiene (159) 159
medical or veterinary science (159) 159
optical elements, systems, or apparatus (154) 154
microbiology (147) 147
biochemistry (146) 146
preparations for medical, dental, or toilet purposes (145) 145
beer (141) 141
enzymology (141) 141
mutation or genetic engineering (141) 141
spirits (141) 141
vinegar (141) 141
wine (141) 141
immunohistochemistry (124) 124
animals (123) 123
carcinoma (123) 123
culture media (115) 115
testing (115) 115
mechanical engineering (113) 113
blasting (112) 112
compositions thereof (112) 112
heating (112) 112
lighting (112) 112
measuring (112) 112
microorganisms or enzymes (112) 112
propagating, preserving or maintaining microorganisms (112) 112
weapons (112) 112
expression (111) 111
organic chemistry (108) 108
specific therapeutic activity of chemical compounds ormedicinal preparations (108) 108
analysis (107) 107
basic electric elements (106) 106
pathology (103) 103
neoplasm staging (101) 101
investigating or analysing materials by determining theirchemical or physical properties (100) 100
compositions based thereon (98) 98
organic macromolecular compounds (98) 98
tumors (98) 98
gastroenterology & hepatology (97) 97
lung neoplasms - pathology (97) 97
their preparation or chemical working-up (97) 97
mice (96) 96
adenocarcinoma (93) 93
medicine & public health (92) 92
metastasis (91) 91
general tagging of cross-sectional technologies spanning over several sections of the ipc (89) 89
general tagging of new technological developments (89) 89
foods or foodstuffs (88) 88
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (88) 88
their treatment, not covered by other classes (87) 87
retrospective studies (86) 86
peptides (84) 84
neoplasm invasiveness (83) 83
survival (83) 83
adenocarcinoma - pathology (77) 77
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (75) 75
macromolecular compounds obtained by reactions only involvingcarbon-to-carbon unsaturated bonds (75) 75
treatment outcome (74) 74
preservation of foods or foodstuffs, in general (73) 73
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (73) 73
research (72) 72
lymphatic metastasis (71) 71
compositions or test papers therefor (68) 68
condition-responsive control in microbiological orenzymological processes (68) 68
measuring or testing processes involving enzymes, nucleicacids or microorganisms (68) 68
processes of preparing such compositions (68) 68
vehicles in general (67) 67
stomach neoplasms - pathology (66) 66
chemotherapy (64) 64
survival rate (63) 63
cell line, tumor (61) 61
colorectal cancer (60) 60
electric communication technique (60) 60
abridged index medicus (58) 58
surgical oncology (57) 57
technologies or applications for mitigation or adaptation againstclimate change (57) 57
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (56) 56
lung cancer (55) 55
diagnosis (52) 52
follow-up studies (52) 52
compositions of macromolecular compounds (51) 51
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2073) 2073
French (215) 215
Japanese (197) 197
German (147) 147
Chinese (92) 92
Korean (19) 19
Portuguese (11) 11
Spanish (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Kanji no naritachi
: "setsumon kaiji" kara saisentan no kenkyū made
by Ochiai, Atsushi, 1974
2014, Shohan., Chikuma sensho, ISBN 4480015949, Volume 89, 286
Writing | Chinese language | Etymology | History | Chinese characters
Book
Details down arrow
2. Full Text Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma
by Nagatsuma, Akiko Kawano and Aizawa, Masaki and Kuwata, Takeshi and Doi, Toshihiko and Ohtsu, Atsushi and Fujii, Hirofumi and Ochiai, Atsushi
Gastric Cancer, ISSN 1436-3291, 4/2015, Volume 18, Issue 2, pp. 227 - 238
Some tyrosine kinase receptors (RTKs) play critical roles in gastric cancer progression. Not only trastuzumab, but also several other agents targeting RTKs are... 
Immunohistochemistry | Molecular targeted therapy | Gene amplification | Prognosis | Medicine & Public Health | Gastroenterology | Abdominal Surgery | Receptor protein-tyrosine kinases | Oncology | Cancer Research | Surgical Oncology | K-SAM | LABEL PHASE-3 TRIAL | TRASTUZUMAB RESISTANCE | GROWTH-FACTOR RECEPTOR | LUNG-CANCER | ONCOLOGY | GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA | PROGNOSTIC-SIGNIFICANCE | GASTROENTEROLOGY & HEPATOLOGY | GENE COPY NUMBER | MEDIATES RESISTANCE | CLINICOPATHOLOGICAL FEATURES | Proto-Oncogene Proteins c-met - metabolism | Receptor, Epidermal Growth Factor - genetics | Carcinoma, Papillary - genetics | Follow-Up Studies | Receptor, ErbB-2 - genetics | Receptor, Fibroblast Growth Factor, Type 2 - metabolism | Tissue Array Analysis | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Stomach Neoplasms - metabolism | Male | Stomach Neoplasms - pathology | Neoplasm Recurrence, Local - mortality | Carcinoma, Papillary - metabolism | Carcinoma, Papillary - secondary | Immunoenzyme Techniques | Neoplasm Recurrence, Local - pathology | Receptor, Epidermal Growth Factor - metabolism | Adenocarcinoma - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Adenocarcinoma - genetics | Real-Time Polymerase Chain Reaction | Stomach Neoplasms - genetics | Neoplasm Recurrence, Local - metabolism | Neoplasm Invasiveness | RNA, Messenger - genetics | In Situ Hybridization, Fluorescence | Survival Rate | Lymphatic Metastasis | Reverse Transcriptase Polymerase Chain Reaction | Adenocarcinoma - secondary | Proto-Oncogene Proteins c-met - genetics | Carcinoma, Papillary - mortality | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | Neoplasm Staging | Stomach Neoplasms - mortality | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Adenocarcinoma - mortality | Cohort Studies | Adenocarcinoma | Proteins | Chemotherapy | DNA microarrays | Analysis | Development and progression | Health aspects | Stomach cancer | Phosphotransferases | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein–Barr virus status in a large cohort of gastric cancer patients
by Kawazoe, Akihito and Kuwata, Takeshi and Kuboki, Yasutoshi and Shitara, Kohei and Nagatsuma, Akiko Kawano and Aizawa, Masaaki and Yoshino, Takayuki and Doi, Toshihiko and Ohtsu, Atsushi and Ochiai, Atsushi
Gastric Cancer, ISSN 1436-3291, 5/2017, Volume 20, Issue 3, pp. 407 - 415
Antibodies against programmed death 1 (PD-1) and its ligand programmed death ligand 1 (PD-L1) have recently demonstrated promising results in gastric cancer... 
Programmed death ligand 1 | Medicine & Public Health | Tumor-infiltrating lymphocytes | Mismatch repair status | Gastroenterology | Abdominal Surgery | Oncology | Cancer Research | Surgical Oncology | Gastric cancer | Epstein–Barr virus | Programmed death ligand 1 | IMMUNE MICROENVIRONMENT | SAFETY | ANTIBODY | PEMBROLIZUMAB | ONCOLOGY | Epstein-Barr virus | UPDATE | NIVOLUMAB | BLOCKADE | GASTROENTEROLOGY & HEPATOLOGY | Stomach Neoplasms - virology | Tissue Array Analysis | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | DNA Mismatch Repair - genetics | B7-H1 Antigen - metabolism | Lymphocytes, Tumor-Infiltrating - pathology | Survival Analysis | Aged, 80 and over | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Aged | Herpesvirus 4, Human - pathogenicity | Stomach Neoplasms - mortality | Cohort Studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Kōkotsu moji ni rekishi o yomu
by Ochiai, Atsushi, 1974
2008, Chikuma shinsho, ISBN 4480064311, Volume 732., 228
Oracle bones | Writing | Inscriptions, Chinese | Chinese language | Jia gu style | Paleography, Chinese
Book
Details down arrow
5. Kōkotsu moji no yomikata
by Ochiai, Atsushi, 1974
2007, Kōdansha gendai shinsho, ISBN 4062879050, Volume 1905, 235
Oracle bones | Inscriptions, Chinese
Book
Details down arrow
6. Full Text ARID2 modulates DNA damage response in human hepatocellular carcinoma cells
by Oba, Atsushi and Shimada, Shu and Akiyama, Yoshimitsu and Nishikawaji, Taketo and Mogushi, Kaoru and Ito, Hiromitsu and Matsumura, Satoshi and Aihara, Arihiro and Mitsunori, Yusuke and Ban, Daisuke and Ochiai, Takanori and Kudo, Atsushi and Asahara, Hiroshi and Kaida, Atsushi and Miura, Masahiko and Tanabe, Minoru and Tanaka, Shinji
Journal of Hepatology, ISSN 0168-8278, 2017, Volume 66, Issue 5, pp. 942 - 951
Graphical abstract 
Gastroenterology and Hepatology | CRISPR/Cas9 | DNA damage response | SWI/SNF | Hepatocellular carcinoma | Nucleotide excision repair | XPC | Benzo[a]pyrene | ARID2 | XPG | PATHWAYS | METASTASIS | LANDSCAPE | CANCER | NUCLEOTIDE EXCISION-REPAIR | MELANOMA | GENE | MUTATIONS | PARP INHIBITORS | BLOCKADE | GASTROENTEROLOGY & HEPATOLOGY | Transcription Factors - physiology | Reactive Oxygen Species - metabolism | Ultraviolet Rays | Liver Neoplasms - genetics | Carcinoma, Hepatocellular - genetics | DNA Repair | Humans | Computational Biology | Cell Line, Tumor | DNA Damage | Mutation | Apoptosis | Genetic aspects | DNA repair | DNA damage | DNA | Cancer | CRISPR | Transcription factors | U.V. radiation | Therapeutic applications | Genes | Ferric chloride | Xeroderma pigmentosum | Benzo(a)pyrene | Gene expression | Liver cancer | Pyrene | Carcinogens | Polycyclic aromatic hydrocarbons | Cell lines | Tumor suppressor genes | Complementation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients
by Fuse, Nozomu and Kuboki, Yasutoshi and Kuwata, Takeshi and Nishina, Tomohiro and Kadowaki, Shigenori and Shinozaki, Eiji and Machida, Nozomu and Yuki, Satoshi and Ooki, Akira and Kajiura, Shinya and Kimura, Tetsuo and Yamanaka, Takeharu and Shitara, Kohei and Nagatsuma, Akiko Kawano and Yoshino, Takayuki and Ochiai, Atsushi and Ohtsu, Atsushi
Gastric Cancer, ISSN 1436-3291, 1/2016, Volume 19, Issue 1, pp. 183 - 191
This study was conducted to investigate whether human epidermal growth factor receptor 2 (HER2) status, epidermal growth factor receptor (EGFR) status, and... 
Gastroesophageal junction cancer | Medicine & Public Health | Human epidermal growth factor receptor 2 | Gastroenterology | Abdominal Surgery | Oncology | Cancer Research | c-MET | Surgical Oncology | Gastric cancer | Epidermal growth factor receptor | 1ST-LINE TREATMENT | CLINICAL-FEATURES | LABEL PHASE-3 TRIAL | GROWTH-FACTOR RECEPTOR | OVEREXPRESSION | ONCOLOGY | DOUBLE-BLIND | CARCINOMAS | ESOPHAGOGASTRIC JUNCTION | GASTROENTEROLOGY & HEPATOLOGY | GENE COPY NUMBER | EXPRESSION | Proto-Oncogene Proteins c-met - metabolism | Receptor, Epidermal Growth Factor - genetics | Adenocarcinoma - pathology | Prognosis | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Male | Stomach Neoplasms - pathology | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Receptor, Epidermal Growth Factor - metabolism | Biomarkers, Tumor - metabolism | Esophageal Neoplasms - mortality | Female | Adenocarcinoma - genetics | Retrospective Studies | Stomach Neoplasms - genetics | Esophagogastric Junction - pathology | Oxonic Acid - administration & dosage | Stomach Neoplasms - drug therapy | Proto-Oncogene Proteins c-met - genetics | Esophageal Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Biomarkers, Tumor - genetics | Stomach Neoplasms - mortality | Drug Combinations | Adenocarcinoma - mortality | Immunohistochemistry | Cancer patients | Care and treatment | Chemotherapy | Patient outcomes | Analysis | Cytogenetics | Stomach cancer | Formaldehyde | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Automated histological classification of whole-slide images of gastric biopsy specimens
by Yoshida, Hiroshi and Shimazu, Taichi and Kiyuna, Tomoharu and Marugame, Atsushi and Yamashita, Yoshiko and Cosatto, Eric and Taniguchi, Hirokazu and Sekine, Shigeki and Ochiai, Atsushi
Gastric Cancer, ISSN 1436-3291, 3/2018, Volume 21, Issue 2, pp. 249 - 257
Automated image analysis has been developed currently in the field of surgical pathology. The aim of the present study was to evaluate the classification... 
Gastric biopsy | Medicine & Public Health | Histopathological classification | Gastroenterology | Automated image analysis | Abdominal Surgery | Oncology | Cancer Research | Surgical Oncology | Artificial intelligence | ONCOLOGY | DIGITAL PATHOLOGY | SURGICAL PATHOLOGY | CYTOLOGY | GASTROENTEROLOGY & HEPATOLOGY | CANCER | Analysis | Machine learning | Automation | Adenoma | Image processing | Biopsy | Classification | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A novel gene–protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity
by Nishida, Yasunori and Kuwata, Takeshi and Nitta, Hiroaki and Dennis, Eslie and Aizawa, Masaki and Kinoshita, Takahiro and Ohtsu, Atsushi and Ochiai, Atsushi
Gastric Cancer, ISSN 1436-3291, 7/2015, Volume 18, Issue 3, pp. 458 - 466
Human epidermal growth factor receptor 2 (HER2) protein overexpression and gene amplification are important biomarkers for trastuzumab treatment in breast and... 
Immunohistochemistry | Medicine & Public Health | Gastroenterology | Abdominal Surgery | Tumor heterogeneity | Oncology | Cancer Research | HER2 | Gene–protein assay | Surgical Oncology | Gastric cancer | Gene-protein assay | TRASTUZUMAB | IN-SITU HYBRIDIZATION | VALIDATION | BREAST-CANCER | ONCOLOGY | CARCINOMAS | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Stomach Neoplasms - genetics | Molecular Diagnostic Techniques - methods | Receptor, ErbB-2 - genetics | Biomarkers, Tumor - analysis | Tissue Array Analysis | Humans | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Stomach Neoplasms - metabolism | Stomach Neoplasms - pathology | Biomarkers, Tumor - metabolism | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | In Situ Hybridization, Fluorescence - methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101)
by Matsusaka, Satoshi and Nashimoto, Atsushi and Nishikawa, Kazuhiro and Miki, Akira and Miwa, Hiroto and Yamaguchi, Kazuya and Yoshikawa, Takaki and Ochiai, Atsushi and Morita, Satoshi and Sano, Takeshi and Kodera, Yasuhiro and Kakeji, Yoshihiro and Sakamoto, Junichi and Saji, Shigetoyo and Yoshida, Kazuhiro
Gastric Cancer, ISSN 1436-3291, 7/2016, Volume 19, Issue 3, pp. 839 - 851
Human epidermal growth factor (HER) 2 positivity and its association with clinicopathological factors remain unclear in Japanese gastric cancer (GC) patients.... 
Immunohistochemistry | Human ERBB2 protein | Medicine & Public Health | Gastroenterology | Fluorescence in situ hybridization | Abdominal Surgery | Oncology | Cancer Research | Surgical Oncology | Stomach neoplasms | PROGNOSIS | ADENOCARCINOMA | INTESTINAL-TYPE | GROWTH-FACTOR RECEPTOR | SPECIMENS | ERBB-2 | AMPLIFICATION | C-ERBB-2 | ONCOLOGY | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | EXPRESSION | Prognosis | Follow-Up Studies | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Stomach Neoplasms - metabolism | Male | Stomach Neoplasms - pathology | Immunoenzyme Techniques | Neoplasm Recurrence, Local - pathology | Young Adult | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Liver Neoplasms - secondary | Peritoneal Neoplasms - secondary | Stomach Neoplasms - genetics | Liver Neoplasms - genetics | Neoplasm Recurrence, Local - metabolism | Neoplasm Invasiveness | In Situ Hybridization, Fluorescence | Lymphatic Metastasis | Peritoneal Neoplasms - genetics | Peritoneal Neoplasms - metabolism | Liver Neoplasms - metabolism | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | Neoplasm Staging | Epidermal growth factor | Analysis | Oncology, Experimental | Fluorescence | Research | Stomach cancer | Formaldehyde | Cancer | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma
by Oba, Atsushi and Ban, Daisuke and Kirimura, Susumu and Akahoshi, Keiichi and Mitsunori, Yusuke and Matsumura, Satoshi and Ochiai, Takanori and Kudo, Atsushi and Tanaka, Shinji and Minoru, Tanabe
Journal of Hepato‐Biliary‐Pancreatic Sciences, ISSN 1868-6974, 08/2016, Volume 23, Issue 8, pp. 480 - 488
Highlight Among several biomarkers reported to predict response to a particular chemotherapy for pancreatic ductal adenocarcinoma, hENT1 and HuR were found to... 
Biomarker | hENT1 | HuR | Personalized therapy | Pancreatic ductal adenocarcinoma | HENT1 | SURVIVAL | SURGERY | DIHYDROPYRIMIDINE DEHYDROGENASE | PHASE-II | TOXICITY | RANDOMIZED CONTROLLED-TRIAL | CANCER | GEMCITABINE PLUS S-1 | SURGICAL RESECTION | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Immunohistochemistry | Adenocarcinoma - pathology | Lymph Nodes - pathology | Prognosis | Humans | Middle Aged | Male | Carcinoma, Pancreatic Ductal - surgery | Patient Selection | Pancreatic Neoplasms - drug therapy | Statistics, Nonparametric | Aged, 80 and over | Biomarkers, Tumor - metabolism | Carcinoma, Pancreatic Ductal - mortality | Female | Pancreatic Neoplasms - mortality | Retrospective Studies | Chemotherapy, Adjuvant | Precision Medicine | Risk Assessment | Deoxycytidine - administration & dosage | Japan | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Hospitals, University | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Oxonic Acid - administration & dosage | Adenocarcinoma - drug therapy | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - drug therapy | Disease-Free Survival | Tegafur - administration & dosage | Aged | Biopsy, Needle | Deoxycytidine - analogs & derivatives | Drug Combinations | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Cohort Studies | Pancreatectomy - methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial)
by Matsumoto, Tomohiro and Sasako, Mitsuru and Mizusawa, Junki and Hirota, Seiichi and Ochiai, Atsushi and Kushima, Ryoji and Katai, Hitoshi and Tanaka, Yoichi and Fukushima, Norimasa and Nashimoto, Atsushi and Tsuburaya, Akira and Stomach Canc Study Grp Japan Clini and Stomach Cancer Study Group of the Japan Clinical Oncology Group
Gastric Cancer, ISSN 1436-3291, 7/2015, Volume 18, Issue 3, pp. 467 - 475
Human epidermal growth factor receptor 2 (HER2) is likely overexpressed and/or amplified in locally advanced gastric cancer with extensive (bulky N2 or... 
Immunohistochemistry | Medicine & Public Health | Gastroenterology | Abdominal Surgery | Oncology | Cancer Research | Gastric adenocarcinoma | HER2 status | Surgical Oncology | Trastuzumab | ADJUVANT CHEMOTHERAPY | ADENOCARCINOMA | HER2-POSITIVE BREAST-CANCER | PROGNOSTIC-FACTOR | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | DISSECTION | GENE AMPLIFICATION | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | ASSOCIATION | Adenocarcinoma - pathology | Lymph Nodes - pathology | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Stomach Neoplasms - metabolism | In Situ Hybridization, Fluorescence | Male | Stomach Neoplasms - pathology | Survival Rate | Lymphatic Metastasis | Adenocarcinoma - metabolism | Adult | Female | Aged | Stomach Neoplasms - surgery | Stomach Neoplasms - mortality | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Costen's syndrome improved by revision of tooth contacting habit
by Ochiai, Atsushi
Otolaryngology - Head and Neck Surgery (Japan), ISSN 0914-3491, 01/2018, Volume 90, Issue 1, pp. 97 - 100
Journal Article
Details down arrow
14. Full Text Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
by Watanabe, Toshiaki and Itabashi, Michio and Shimada, Yasuhiro and Tanaka, Shinji and Ito, Yoshinori and Ajioka, Yoichi and Hamaguchi, Tetsuya and Hyodo, Ichinosuke and Igarashi, Masahiro and Ishida, Hideyuki and Ishihara, Soichiro and Ishiguro, Megumi and Kanemitsu, Yukihide and Kokudo, Norihiro and Muro, Kei and Ochiai, Atsushi and Oguchi, Masahiko and Ohkura, Yasuo and Saito, Yutaka and Sakai, Yoshiharu and Ueno, Hideki and Yoshino, Takayuki and Boku, Narikazu and Fujimori, Takahiro and Koinuma, Nobuo and Morita, Takayuki and Nishimura, Genichi and Sakata, Yuh and Takahashi, Keiichi and Tsuruta, Osamu and Yamaguchi, Toshiharu and Yoshida, Masahiro and Yamaguchi, Naohiko and Kotake, Kenjiro and Sugihara, Kenichi and Japanese Soc Canc Colon Rectum and Japanese Society for Cancer of the Colon and Rectum
International Journal of Clinical Oncology, ISSN 1341-9625, 4/2015, Volume 20, Issue 2, pp. 207 - 239
Colorectal cancer is a major cause of death in Japan, where it accounts for the largest number of deaths from malignant neoplasms among women and the third... 
Chemotherapy | Medicine & Public Health | Surgery | Colorectal cancer | Oncology | Cancer Research | Guideline | Endoscopy | Radiotherapy | Surgical Oncology | INTENSIVE FOLLOW-UP | 1ST-LINE TREATMENT | FLUOROURACIL PLUS LEUCOVORIN | TOTAL MESORECTAL EXCISION | HEPATIC METASTASES | LYMPH-NODE METASTASIS | ONCOLOGY | HIGH-DOSE LEUCOVORIN | RANDOMIZED PHASE-III | PREOPERATIVE RADIOTHERAPY | SHORT-COURSE RADIOTHERAPY | Colonic Neoplasms - therapy | Lymph Node Excision | Humans | Japan | Neoplasm Recurrence, Local - therapy | Endoscopy, Gastrointestinal | Male | Palliative Care | Liver Neoplasms - therapy | Lymphatic Metastasis | Rectal Neoplasms - therapy | Intestinal Mucosa - surgery | Brain Neoplasms - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Brain Neoplasms - therapy | Female | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Neoplasm Staging | Radiotherapy, Adjuvant | Dissection | Practice guidelines (Medicine) | Care and treatment | Cancer | Index Medicus | Special
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Combined mutation of Apc, Kras, and Tgfbr2 effectively drives metastasis of intestinal cancer
by Sakai, Eri and Nakayama, Mizuho and Oshima, Hiroko and Kouyama, Yuta and Niida, Atsushi and Fujii, Satoshi and Ochiai, Atsushi and Nakayama, Keiichi I and Mimori, Koshi and Suzuki, Yutaka and Hong, Chang Pyo and Ock, Chan-Young and Kim, Seong-Jin and Oshima, Masanobu
Cancer Research, ISSN 0008-5472, 03/2018, Volume 78, Issue 5, pp. 1334 - 1346
Colorectal cancer is driven by the accumulation of driver mutations, but the contributions of specific mutations to different steps in malignant progression... 
CONDITIONAL INACTIVATION | STEM-CELLS | MICROENVIRONMENT | ONCOLOGY | COLORECTAL-CANCER | GROWTH | ACQUISITION | MUTANT P53 | TUMOR-SUPPRESSOR | DIFFERENTIATION | GENOME | Adenomatous Polyposis Coli Protein - genetics | Liver Neoplasms - genetics | Signal Transduction | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Mice, Inbred C57BL | Gene Expression Regulation, Neoplastic | Gene Expression Profiling | Mice, SCID | Biomarkers, Tumor | Disease Progression | Intestinal Neoplasms - pathology | Animals | Receptor, Transforming Growth Factor-beta Type II - genetics | Mice, Inbred NOD | Mice | Mutation | Tumor Cells, Cultured | Liver Neoplasms - secondary | TRPC Cation Channels - genetics | Intestinal Neoplasms - genetics | Disease Models, Animal | Animal models | Wnt protein | Mesenchyme | Epithelial cells | Liver | Colorectal carcinoma | Colorectal cancer | Transplantation | Metastasis | Gene deletion | Cdc4 protein | Metastases | Gene sequencing | Prevention | Colon cancer | Clonal deletion | Organoids | Intestine | Deletion | Colon | Genotypes | Spleen | Invasiveness | Histology | Gene expression | Ribonucleic acid--RNA | Adenomatous polyposis coli | Signaling | Tumors | Cancer | Liver transplantation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights